IPO Details
Bidding Dates
05 Feb '25 - 07 Feb '25
Minimum Investment
₹1,33,200/ 1 Lot (1,200 Shares)
Price Range
₹105-₹111
Maximum Investment
₹1,33,200/ 1 Lot (1,200 Shares)
Retail Discount
To be announced
Issue Size
₹59.98 Cr
Investor category and sub category
Retail Individual Investors (RII) | Non-institutional Investors (NII) | Qualified Institutional Buyers (QIB) |Amwill Healthcare IPO Important Dates
Important dates with respect to IPO allotment and listing
IPO Opening Date
Feb 05, 25
IPO Closing Date
Feb 07, 25
Basis of Allotment
Feb 10, 25
Initiation of Refunds
Feb 11, 25
IPO Listing Date
Feb 12, 25
Amwill Healthcare IPO Subscription Details
Date | QIB | NII | Retail | Total |
---|---|---|---|---|
Day 1Feb 4, 2025 |
2.19 | 0.51 | 1 | 1.04 |
Day 2Feb 5, 2025 |
2.19 | 0.41 | 1.24 | 1.1 |
About Amwill Healthcare IPO
Amwill Healthcare IPO is a book-built issue worth ₹59.98 crore, consisting of a fresh issue of 44.04 lakh shares totaling ₹48.88 crore and an offer for sale of 10 lakh shares amounting to ₹11.10 crore. The IPO opened for subscription on February 5, 2025, and will close tomorrow on February 7, 2025. The allotment is expected to be finalised on February 10, 2025, with a tentative listing date on BSE SME set for February 12, 2025.
The IPO price band has been set between ₹105 and ₹111 per share. Retail investors need to apply for a minimum lot size of 1,200 shares, requiring an investment of ₹1,33,200. High Net Worth Individuals (HNIs) must invest in at least two lots (2,400 shares), amounting to ₹2,66,400.
Unistone Capital Pvt Ltd is the book-running lead manager for the IPO, while Bigshare Services Pvt Ltd is the registrar. Globalworth Securities Limited is the market maker. Investors can refer to the Red Herring Prospectus (RHP) for comprehensive details on the IPO.
Industry Outlook
- India’s beauty and personal care industry, valued at $14 billion, is experiencing rapid growth due to online retail expansion, premiumisation, and increased demand for organic products. Internet sales in this category surged to $400 million from $100 million in 2014, reflecting the shift towards digital platforms like Nykaa and Amazon.
- The rise in smartphone penetration and internet access among 560 million Indians is further driving industry growth. By 2025, India's internet user base is expected to surpass Europe’s population, accelerating digital engagement and online retailing in beauty and personal care.
Amwill Healthcare IPO Objectives
The company plans to allocate the net proceeds from the issuance to the following purposes:
- ₹2,500 lakh will be allocated to support daily operations, ensuring smooth business activities and financial stability.
- ₹500 lakh will be used to enhance brand visibility and expand market reach through targeted marketing campaigns.
- The remaining funds will be used for general corporate purposes.
About Amwill Healthcare Limited
Amwill Healthcare Limited is a derma-cosmetic development company focused on formulating innovative skincare solutions. By collaborating with contract manufacturers, distributors, and third-party developers, the company has built strong capabilities in manufacturing, packaging, and distribution. The core objective is to develop dermatological, cosmeceutical, and aesthetic products that address specific skin concerns.
Operating primarily in Karnataka, Andhra Pradesh, and Telangana, the company aims to strengthen its presence before expanding into new markets. Its product portfolio is divided into two categories: generic dermatological solutions and specialised formulations for specific skin conditions. The company's expertise in product development is backed by the experience of its Managing Director, Anand Gandhi, who previously operated under M/s. Amwill Healthcare. In 2020, intellectual property rights for the products developed under M/s. Amwill Healthcare was transferred to Amwill Healthcare Limited.
With continuous innovation, 7 new products have been introduced, including XL Hydra Cream, Ultra Kromaglo Effervescent Tablets, and Depimed Ultra Cream. The company collaborates closely with dermatologists and medical professionals to identify market gaps and develop effective formulations for conditions such as acne, fungal infections, and vitiligo.
Manufacturing is outsourced to certified contract manufacturers who ensure quality compliance. The company has also partnered with M/s. Amderma Healthcare LLP for product storage and distribution. This structured approach allows Amwill Healthcare Limited to focus entirely on product research and development while ensuring efficient market penetration.
How To Check the Allotment Status of Amwill Healthcare IPO?
Steps to check IPO allotment status on Angel One’s app:
- Log in to the Angel One app.
- Go to the IPO Section and then to IPO Orders.
- Select the individual IPO that you had applied for and check the allotment status.
- Angel One will notify you of your IPO allotment status via push notification and email.
How To Apply for the Amwill Healthcare IPO Online?
- Login to Your Angel One Account: Open the Angel One app or website and log in with your credentials.
- Locate the IPO Section: Navigate to the 'IPO' section on the platform.
- Select IPO: Find and select the Amwill Healthcare IPO from the list of open IPOs.
- Enter the Lot Size: Specify the number of lots you want to bid for.
- Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.
- Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.
Contact Details of Amwill Healthcare IPO
Registered office: No. 90, 4th Floor, 2nd Main, 7th Cross, Chamrajpet, Bangalore – 560 018, Karnataka, India.
Phone: +91 802 660 5825
E-mail: amwill@amwillhealthcare.com
Amwill Healthcare IPO Reservation
Investor Category |
Shares Offered |
Anchor Investor |
- |
Market Maker |
2,71,200 (5.02%) |
QIB |
10,26,000 (18.99%) |
NII (HNI) |
20,53,200 (38%) |
Retail |
20,53,200 (38%) |
Amwill Healthcare IPO Lot Size
Application |
Lots |
Shares |
Amount |
Retail (Min) |
1 |
1,200 |
₹1,33,200 |
Retail (Max) |
1 |
1,200 |
₹1,33,200 |
HNI (Min) |
2 |
2,400 |
₹2,66,400 |
Amwill Healthcare IPO Promoter Holding
The promoters of the company are Anand Gandhi and Tarun Gandhi.
Share Holding Pre-Issue |
97.00% |
Share Holding Post Issue |
- |
Key Performance Indicators for Amwill Healthcare IPO
As of March 31, 2024, the market capitalisation of Amwill Healthcare's IPO is ₹222.04 crore. Here are the KPIs of Amwill Healthcare:
KPI |
Value |
RoE (%) |
73.06 |
RoCE (%) |
94.16 |
Price to Book Value |
10.09 |
PAT Margin |
28.53 |
Price Metrics
Metric |
Pre-IPO |
Post-IPO |
EPS (₹) |
8.04 |
6.52 |
P/E (x) |
13.81 |
17.04 |
Note: Pre-IPO EPS is based on pre-issue shareholding as of the RHP date and FY earnings as of March 31, 2024. Post-IPO EPS is based on post-issue shareholding and annualised FY earnings as of September 30, 2024, as per RHP.
Amwill Healthcare IPO Prospectus
Amwill Healthcare IPO Registrar and Lead Managers
Amwill Healthcare IPO Lead Managers
- Unistone Capital Pvt Ltd
Registrar for Amwill Healthcare IPO
Bigshare Services Pvt Ltd
- Contact Number:+91-22-6263 8200
- Email Address: investor@bigshareonline.com
Amwill HealthcareIPO Registrar
Financial Performance of Amwill Healthcare Limited
Particulars | Year ending on March 31, 2024 | Year ending on March 31, 2023 | Year ending on March 31, 2022 |
---|---|---|---|
Revenue from Operation (in ₹ lakh) | 4,394.83 | 3,016.63 | 2,761.32 |
Profit After Tax (PAT) (in ₹ lakh) | 1,253.63 | 311.44 | 257.37 |
EPS (Earnings per Share in ₹) | 8.04 | 2.00 | 1.65 |
Current Ratio (x) | 11.39 | 1.51 | 1.13 |
Return on equity (%) | 73.06 | 67.67 | 172.97 |
Return on capital employed (%) | 94.16 | 83.32 | 204.08 |
EBITDA (in ₹ lakh) | 1,666.69 | 429.56 | 366.00 |
Know before investing
Strengths
8-
Outsourced manufacturing and distribution reduce costs and enhance flexibility.
-
Specialises in derma-cosmetic products with innovative formulations.
-
Promoters have 20+ years of expertise in pharmaceuticals.
-
Collaborates with contract manufacturers for high-standard product development.
-
Recently entered West Bengal and Odisha to boost sales.
-
Strengthening sales team to enhance domestic and international reach.
-
Uses Amderma Healthcare LLP for seamless product storage and delivery.
-
Focuses on innovation, new formulations, and market expansion.
Risks
8-
Amwill Healthcare Limited relies entirely on Amderma Healthcare LLP for revenue.
-
Any breach of agreement by Amderma Healthcare LLP may harm operations.
-
Outsourcing manufacturing and distribution increases dependency on third-party service providers.
-
Limited product innovation may impact future revenue and profitability growth.
-
Revenue concentration in select states exposes business to regional economic risks.
-
Failure to collect dues from Amderma Healthcare LLP may impact cash flow.
-
Credit risk due to extended receivable periods may affect profit margins.
-
Promoter Group entities engaged in similar businesses may create conflicts of interest.

Login to Angel One App / Website & click on IPO

Select desired IPO & tap on "Apply"

Enter UPI ID, set quantity/price & submit

Accept mandate on the UPI app to complete the process

Login to Angel One App / Website

Choose IPO section on Home Page

Click IPO Orders

Chose the IPO application you want to view the status for
Amwill Healthcare Limited Peer Comparison
Company Name | EPS (Basic) | NAV (per share) (₹) | P/E (x) | RoNW (%) |
---|---|---|---|---|
Amwill Healthcare Limited | 8.04 | 11 | - | 73.06 |
Vaishali Pharma Limited | 0.68 | 39.97 | 26.45 | 1.68 |
Trident Lifeline Limited | 6.13 | 45.81 | 45.06 | 13.37 |
Amwill Healthcare IPO FAQs

Amwill Healthcare IPO is a book-built issue IPO. It will be open from February 5, 2025, to February 7, 2025.

The Basis of Allotment will happen on Monday, February 10, 2025.

The IPO subscription window will open on February 5, 2025.

The minimum lot size retail investors can subscribe to is 1 lot, and the lot size is 1,200 shares.

The listing date for Amwill Healthcare Limited is Wednesday, February 12, 2025.

The issue size of the Amwill Healthcare IPO is up to ₹59.98 crore, with a fresh issue of ₹48.88 crore and the remaining amount of ₹11.10 crore for Offer for Sale.

The open and close dates for Amwill Healthcare IPO are from February 5, 2025, to February 7, 2025.

Listing gains cannot be ascertained before the listing of the IPO on the stock exchange.

- Multiple Submissions: Use different Demat accounts to make multiple applications.
- Higher Price Band Bidding: Opt for bidding at the cut-off price or higher price band.
- Timely Subscription: Ensure you subscribe to the IPO within the specified time frame.

You must complete the payment process by logging in to your UPI handle and approving the payment mandate.

You can submit only one application using your PAN card.

To read Amwill Healthcare Limited’s financial statements, download the IPO’s RHP document.

Pre-apply allows investors to apply for the Amwill Healthcare IPO two days before the subscription period opens, ensuring an early submission of your application.

Your order will be placed when the IPO opens for bidding, and a UPI request will follow within 24 hours.

You will receive a notification once your order is successfully placed with the exchange after the bidding starts.

Bigshare Services Pvt Ltd is the registrar responsible for managing the IPO allotment process and handling investor queries.

Amwill Healthcare IPO is proposed to be listed on the SME platform of the Bombay Stock Exchange (BSE).